Literature DB >> 9325171

Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum.

A Menegon1, C Leoni, F Benfenati, F Valtorta.   

Abstract

We have investigated the effect of extracellularly applied Tat protein of the human immunodeficiency virus type 1 (HIV-1) on tyrosine phosphorylation processes, which represent a major signal transduction pathway of cells of the central nervous system. Primary cultures of rat cerebellar astrocytes or granule cells were incubated with synthetic Tat (10 ng/ml) for various periods of time and analyzed for their phosphotyrosine content by Western blotting. In both types of cultures Tat was able to induce the phosphorylation of mitogen-activated protein kinase (MAP kinase) on tyrosine residues, although with different kinetics and isoform specificity. In addition, in neuronal cells, but not in astrocytes, Tat increased the phosphotyrosine content of Shc, a protein involved in signal transduction downstream of receptor tyrosine kinase activation. This study shows that Tat applied extracellularly is able to induce the generation of intracellular signals in neuronal as well as glial cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325171     DOI: 10.1006/bbrc.1997.7393

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro.

Authors:  Antonio Contestabile
Journal:  Cerebellum       Date:  2002 Jan-Mar       Impact factor: 3.847

2.  Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload.

Authors:  Sylvia Fitting; Pamela E Knapp; Shiping Zou; William D Marks; M Scott Bowers; Hamid I Akbarali; Kurt F Hauser
Journal:  J Neurosci       Date:  2014-09-17       Impact factor: 6.167

3.  Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes.

Authors:  O Kutsch; J Oh; A Nath; E N Benveniste
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Ketone bodies protection against HIV-1 Tat-induced neurotoxicity.

Authors:  Liang Hui; Xuesong Chen; Dhaval Bhatt; Nicholas H Geiger; Thad A Rosenberger; Norman J Haughey; Susan A Masino; Jonathan D Geiger
Journal:  J Neurochem       Date:  2012-05-17       Impact factor: 5.372

Review 5.  Molecular targets of opiate drug abuse in neuroAIDS.

Authors:  K F Hauser; N El-Hage; S Buch; J R Berger; W R Tyor; A Nath; A J Bruce-Keller; P E Knapp
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

6.  Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation.

Authors:  C M McManus; K Weidenheim; S E Woodman; J Nunez; J Hesselgesser; A Nath; J W Berman
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

7.  Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis.

Authors:  Sylvia Fitting; Shiping Zou; Wen Chen; Phu Vo; Kurt F Hauser; Pamela E Knapp
Journal:  J Proteome Res       Date:  2010-04-05       Impact factor: 4.466

8.  Fibronectin modulates the effects of HIV-1 Tat on the growth of murine Kaposi's sarcoma-like cells through the down-regulation of tyrosine phosphorylation.

Authors:  Z Wu; U Cavallaro; P C Marchisio; M R Soria; J A Maier
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

9.  Functional domains of Tat required for efficient human immunodeficiency virus type 1 reverse transcription.

Authors:  C Ulich; A Dunne; E Parry; C W Hooker; R B Gaynor; D Harrich
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Spatial and temporal regulation of Ca2+/calmodulin-dependent protein kinase II activity in developing neurons.

Authors:  Andrea Menegon; Claudia Verderio; Chiara Leoni; Fabio Benfenati; Andrew J Czernik; Paul Greengard; Michela Matteoli; Flavia Valtorta
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.